Patients with kind 2nd diabetes now no longer have to worry much because Victoza has been passed by FDA. For safety reasons, they first suspended Victoza approval for about ten months. The biochemical applied science association will ascertain a huge gain in revenue from 2015; however they are also looking for the similar sort of drugs that will make huge money for them.

The researchers have shown that Victoza causes pancreatitis that is the enlargement of pancreas. After injecting hormone named GLP-1 pancreas starts producing insulin, on the other hand this medicine also causes the throid malignant tumor and therefore the need is to reduce this risk.

The FDA told that told that in nearly 4000 patients the pancreatitis happened in 5 clinical trials that used this drug instead of using other medicine concerning this disease. If any one feels intense pain in abdominal muscles he should stop using this medicine and the advice for these patients is do not start it until you have you blood test and it confirmed the inflammation of your pancreas. So the patients of pancreatitis should take this medicine with extreme care.

So these safety reasons made the FDA continuously researching the bad and good effects of Victoza for ten months, but the associations who expect their huge profit by selling this medicine as well as the related medicine.

The FDA is concentrating on the bad and good of the already passed out medicines for the treatment of diabetes. The Citi IRA remarked about the growing portions of other medicine such as Amylin that has a price of forteen to twenty seven dollars and another person of IRA re-assigned the price as twenty to twenty four.

Victoza